Vaš brskalnik ne omogoča JavaScript!
JavaScript je nujen za pravilno delovanje teh spletnih strani. Omogočite JavaScript ali pa uporabite sodobnejši brskalnik.
Repozitorij Univerze v Ljubljani
Nacionalni portal odprte znanosti
Odprta znanost
DiKUL
slv
|
eng
Iskanje
Napredno
Novo v RUL
Kaj je RUL
V številkah
Pomoč
Prijava
Podrobno
Lead optimization : synthesis and biological evaluation of griseofulvin derivatives as novel SIRT6 activators
ID
Zorko, Tilen
(
Avtor
),
ID
Kogovšek, Jan
(
Avtor
),
ID
Ciber, Luka
(
Avtor
),
ID
Ostojić, Ivana
(
Avtor
),
ID
Maraš, Nenad
(
Avtor
),
ID
Novinec, Marko
(
Avtor
),
ID
Štefane, Bogdan
(
Avtor
)
PDF - Predstavitvena datoteka,
prenos
(2,47 MB)
MD5: C1898C11773CF887154F6CA06C5FC32A
URL - Izvorni URL, za dostop obiščite
https://pubs.acs.org/doi/10.1021/acsmedchemlett.5c00690
Galerija slik
Izvleček
SIRT6, a crucial regulator of aging and cellular homeostasis, represents a promising target for small-molecule activation. In this study, we investigate griseofulvin and its derivatives as novel SIRT6 activators, focusing on the recently developed compound forvisirvat, which has progressed to Phase 2 clinical study. Biochemical evaluation revealed that griseofulvin itself possesses strong SIRT6-activating properties, achieving up to 10-fold activity at 100 μM. Modification of the griseofulvin scaffold generally led to reduced activity, prompting a focus on the oxadiazole moiety of forvisirvat. This strategy produced several analogues with higher potency, the most active at 100 μM being para-1,3,4-oxadiazolephenyl analog 21, which achieved 30-fold SIRT6 activation. Compounds bearing para-substituted phenyl rings exhibited excellent retention of activity at lower concentrations, with para-tolyl derivative 24 being the most potent at 10 μM. Retention of activity at pharmacologically relevant concentrations underscores their potential as potent SIRT6 activators and provides a rationale for continued development as drug candidates.
Jezik:
Angleški jezik
Ključne besede:
SIRT6
,
sirtuin activators
,
grisefulvin
,
forvisirvat
,
aging
Vrsta gradiva:
Članek v reviji
Tipologija:
1.01 - Izvirni znanstveni članek
Organizacija:
FKKT - Fakulteta za kemijo in kemijsko tehnologijo
Status publikacije:
Objavljeno
Različica publikacije:
Objavljena publikacija
Leto izida:
2026
Št. strani:
Str. 662-669
Številčenje:
Vol. 17, iss. 3
PID:
20.500.12556/RUL-180760
UDK:
547.7:577.24
ISSN pri članku:
1948-5875
DOI:
10.1021/acsmedchemlett.5c00690
COBISS.SI-ID:
270595331
Datum objave v RUL:
16.03.2026
Število ogledov:
113
Število prenosov:
30
Metapodatki:
Citiraj gradivo
Navadno besedilo
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Kopiraj citat
Objavi na:
Gradivo je del revije
Naslov:
ACS Medicinal Chemistry Letters
Založnik:
American Chemical Society
ISSN:
1948-5875
COBISS.SI-ID:
2959217
Licence
Licenca:
CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:
http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:
To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Sekundarni jezik
Jezik:
Slovenski jezik
Ključne besede:
SIRT6
,
aktivatorji sirtuina
,
griseofulvin
,
forvisirvat
,
staranje
Podobna dela
Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:
Nazaj